Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for analgesia and sedation in neurosurgical ICU patients with severe brain injury
ChiCTR1800019592Phase 4Recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in intracerebral hemorrhage (ICH) and traumatic brain injury (TBI) (2 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoints: Critical-Care Pain Observation Tool score and Richmond Agitation-Sedation Scale. Started Oct 2018; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
intracerebral hemorrhage (ICH)traumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR1800019592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019592.